Document Detail

Plasma-diluted thrombin time to measure dabigatran concentrations during dabigatran etexilate therapy.
MedLine Citation:
PMID:  22431533     Owner:  NLM     Status:  MEDLINE    
New anticoagulants, like the orally available direct thrombin inhibitor (DTI) dabigatran etexilate, have recently been introduced into the market for venous thromboembolic prophylaxis and for stroke prevention in atrial fibrillation. While dabigatran has been approved for use without the need for routine therapeutic monitoring, there are clinical scenarios in which monitoring can help guide clinical management. We report herein the application of a recently described plasma-diluted thrombin time (DTI assay) used to monitor intravenous DTI as a useful and easily implemented method to monitor oral DTIs.
Scott T Avecilla; Chris Ferrell; Wayne L Chandler; Morayma Reyes
Related Documents :
12580933 - Endocrine profiles and semen quality in spinal cord injured men.
15550493 - Diurnal changes in fsh-regulatory peptides and their relationship to gonadotrophins in ...
11135083 - Characterization of tubular functional capacity in humans using para-aminohippurate and...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of clinical pathology     Volume:  137     ISSN:  1943-7722     ISO Abbreviation:  Am. J. Clin. Pathol.     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-03-20     Completed Date:  2012-05-04     Revised Date:  2013-06-03    
Medline Journal Info:
Nlm Unique ID:  0370470     Medline TA:  Am J Clin Pathol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  572-4     Citation Subset:  AIM; IM    
Laboratory Medicine, University of Washington, Seattle, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antithrombin Proteins / administration & dosage,  therapeutic use*
Atrial Fibrillation / drug therapy*
Benzimidazoles / administration & dosage,  therapeutic use*
Dose-Response Relationship, Drug
Pyridines / administration & dosage,  therapeutic use*
Stroke / prevention & control*
Thrombin Time
Reg. No./Substance:
0/Antithrombin Proteins; 0/Benzimidazoles; 0/Pyridines; 2E18WX195X/dabigatran etexilate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A Massive Transfusion Protocol Incorporating a Higher FFP/RBC Ratio Is Associated With Decreased Use...
Next Document:  Comparison of methods for proliferative index analysis for grading pancreatic well-differentiated ne...